+18.7%
MRNA vs ETHA
-27.9%
+46.7%
-81.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | ETHA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +3.2% | +2.1% | +4.3% |
| 7D | -1.1% | +3.5% | -4.5% | -2.2% |
| 30D | +126.1% | +35.3% | +90.8% | +105.0% |
| 3M | +190.0% | +50.9% | +139.2% | +156.7% |
| 6M | +157.2% | +22.1% | +135.1% | +136.6% |
| YTD | +388.2% | -14.6% | +402.8% | +373.6% |
| 1Y | +467.0% | -42.8% | +509.8% | +479.6% |
| All | +18.7% | -27.9% | +46.7% | +10.4% |
Cumulative growth
Daily Returns
Daily percentage return beside ETHA.
Daily Out/Under-Performance
Portfolio return minus ETHA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ETHA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded ETHA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling